de Moerloose P - Search Results

1

Extensive thromboembolic event as initial presentation of monoclonal gammopathy of undetermined significance.

Righini M, Boehlen F, Gueddi S, Le Gal G, de Moerloose P. Righini M, et al. Among authors: de moerloose p. Thromb Haemost. 2006 Jul;96(1):93-4. doi: 10.1160/TH06-02-0123. Thromb Haemost. 2006. PMID: 16807659 No abstract available.

2

Thromboprophylaxis with low-molecular-weight heparin after cesarean delivery.

Blondon M, Perrier A, Nendaz M, Righini M, Boehlen F, Boulvain M, De Moerloose P. Blondon M, et al. Among authors: de moerloose p. Thromb Haemost. 2010 Jan;103(1):129-37. doi: 10.1160/TH09-06-0349. Epub 2009 Oct 26. Thromb Haemost. 2010. PMID: 20062923

3

Severe factor XI deficiency in a Lebanese family: identification of a novel missense mutation (Trp501Cys) in the catalytic domain.

de Moerloose P, Germanos-Haddad M, Boehlen F, Neerman-Arbez M. de Moerloose P, et al. Blood Coagul Fibrinolysis. 2004 Apr;15(3):269-72. doi: 10.1097/00001721-200404000-00013. Blood Coagul Fibrinolysis. 2004. PMID: 15060426

4

Agreement of a new whole-blood PT/INR test using capillary samples with plasma INR determinations.

Boehlen F, Reber G, de Moerloose P. Boehlen F, et al. Among authors: de moerloose p. Thromb Res. 2005;115(1-2):131-4. doi: 10.1016/j.thromres.2004.06.023. Thromb Res. 2005. PMID: 15567464

5

Discrepancy between capillary and venous International Normalised Ratio (INR) in a patient on vitamin-K antagonist: potentially serious clinical consequences.

Waldvogel Abramowski S, Boehlen F, Reber G, de Moerloose P. Waldvogel Abramowski S, et al. Among authors: de moerloose p. Thromb Haemost. 2006 Nov;96(5):688-9. doi: 10.1160/th06-08-0448. Thromb Haemost. 2006. PMID: 17080228 No abstract available.

6

Blood coagulation and fibrinolysis: mechanisms of thrombosis.

de Moerloose P, Boehlen F. de Moerloose P, et al. Handb Clin Neurol. 2009;92:239-46. doi: 10.1016/S0072-9752(08)01912-X. Handb Clin Neurol. 2009. PMID: 18790278 No abstract available.

7

Technical aspects in laboratory testing for antiphospholipid antibodies: is standardization an impossible dream?

Reber G, Boehlen F, de Moerloose P. Reber G, et al. Among authors: de moerloose p. Semin Thromb Hemost. 2008 Jun;34(4):340-6. doi: 10.1055/s-0028-1085476. Epub 2008 Sep 23. Semin Thromb Hemost. 2008. PMID: 18814067 Review.

8

Fibrinogen and the risk of thrombosis.

de Moerloose P, Boehlen F, Neerman-Arbez M. de Moerloose P, et al. Semin Thromb Hemost. 2010 Feb;36(1):7-17. doi: 10.1055/s-0030-1248720. Epub 2010 Apr 13. Semin Thromb Hemost. 2010. PMID: 20391292 Review.

9

Predicting deep venous thrombosis in pregnancy: external validation of the LEFT clinical prediction rule.

Righini M, Jobic C, Boehlen F, Broussaud J, Becker F, Jaffrelot M, Blondon M, Guias B, Le Gal G; EDVIGE study group. Righini M, et al. Haematologica. 2013 Apr;98(4):545-8. doi: 10.3324/haematol.2012.072009. Epub 2012 Oct 12. Haematologica. 2013. PMID: 23065510 Free PMC article. Clinical Trial.

10

Pulmonary embolism and fatal stroke in a patient with severe factor XI deficiency after bariatric surgery.

Boehlen F, Casini A, Pugin F, de Moerloose P. Boehlen F, et al. Among authors: de moerloose p. Blood Coagul Fibrinolysis. 2013 Apr;24(3):347-50. doi: 10.1097/MBC.0b013e32835bdbec. Blood Coagul Fibrinolysis. 2013. PMID: 23187784

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

440 results

Search Page

Filters